Targeted delivery of vitamin D to the colon using β-glucuronides of vitamin D: Therapeutic effects in a murine model of inflammatory bowel disease

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 302, Issue 4, 2012, Pages 460-469

  Goff, Jesse P ^a   Koszewski, Nicholas J ^a   Haynes, Joseph S ^a   Horst, Ronald L ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b Heartland Assays Inc   (United States)

Author keywords

1,25 dihydroxyvitamin D 3; 1,25 dihydroxyvitamin D 3 25 glucuronide; 24 hydroxylase; Dextran sodium sulfate

Indexed keywords

CALCIUM; GLUCURONIDE; VITAMIN D;

24 HYDOXYLASE GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM BLOOD LEVEL; COLITIS; ENTERITIS; ENZYME ACTIVITY; ENZYME INDUCTION; GENE; HYPERCALCEMIA; IN VIVO STUDY; INTESTINE FLORA; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION;

ANIMALS; CALCITRIOL; CALCIUM; COLITIS; COLON; DISEASE MODELS, ANIMAL; DRUG CARRIERS; INFLAMMATORY BOWEL DISEASES; MALE; MICE; TREATMENT OUTCOME; VITAMIN D;

EID: 84856718097     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00156.2011     Document Type: Article

References (29)

1. Baeke F, van Etten E, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol Aspects Med 29: 376-387, 2008.
2. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130: 2648-2652, 2000.
3. Das A, Spackman E, Pantin-Jackwood MJ, Suarez DL. Removal of real-time reverse transcription polymerase chain reaction (RT-PCR) inhibitors associated with cloacal swab samples and tissues for improved diagnosis of avian influenza virus by RT-PCR. J Vet Diagn Invest 21: 771-778, 2009.
4. Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol 173: 1243-1252, 2008.
5. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 8: 5, 2007.
6. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386-401, 2001.
7. Hollis BW. Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 282: 174-186, 1997.
8. 2D: where we are and where we are going. J Steroid Biochem Mol Biol 103: 473-476, 2007.
9. Jain A, Gupta Y, Jain SK. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J Pharm Pharm Sci 10: 86-128, 2007.
10. 3 treatment in Crohn's disease-a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 32: 377-383, 2010.
11. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294: G208-G216, 2008.
12. Lagishetty V, Chun RF, Liu NQ, Lisse TS, Adams JS, Hewison M. 1α-Hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines. J Steroid Biochem Mol Biol 121: 228-233, 2010.
13. Laverny G, Penna G, Vetrano S, Correale C, Nebuloni M, Danese S, Adorini L. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett 131: 49-58, 2010.
14. Leslie WD, Miller N, Rogala L, Bernstein CN. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 103: 1451-1459, 2008.
15. Liu N, Nguyen L, Chun RF, Lagishetty V, Ren S, Wu S, Hollis B, DeLuca HF, Adams JS, Hewison M. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149: 4799-4808, 2008.
16. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773, 2006.
17. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517, 2004.
18. Miheller P, Muzes G, Hritz I, Lakatos G, Pregun I, Lakatos PL, Herszenyi L, Tulassay Z. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis 15: 1656-1662, 2009.
19. Muller B, Becker KL, Kranzlin M, Schachinger H, Huber PR, Nylen ES, Snider RH, White JC, Schmidt-Gayk H, Zimmerli W, Ritz R. Disordered calcium homeostasis of sepsis: association with calcitonin precursors. Eur J Clin Invest 30: 823-831, 2000.
20. Nagubandi S, Kumar R, Londowski JM, Corradino RA, Tietz PS. Role of vitamin-D glucosiduronate in calcium homeostasis. J Clin Invest 66: 1274-1280, 1980.
21. Peyrin-Biroulet L, Oussalah A, Bigard MA. Crohn's disease: the hot hypothesis. Med Hypotheses 73: 94-96, 2009.
22. Rambeck WA, Weiser H, Meier W, Labler L, Zucker H. Biological activity of the 3 mono-β-D-glucopyranosides of 1,25-dihydroxycholecalciferol. Int J Vitam Nutr Res 55: 263-267, 1985.
23. Reinhardt TA, Horst RL. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Endocrinology 127: 942-948, 1990.
24. 3 metabolism limits receptor occupancy and target tissue responsiveness. J Biol Chem 264: 15917-15921, 1989.
25. Shimada K, Sugaya K, Kaji H, Nakatani I, Mitamura K, Tsutsumi N. Syntheses and enzymatic hydrolysis of 25-hydroxyvitamin D monoglucuronides. Chem Pharm Bull 43: 1379-1384, 1995.
26. 3 to "program" T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8: 285-293, 2007.
27. Strauch UG, Obermeier F, Grunwald N, Dunger N, Rath HC, Scholmerich J, Steinmeyer A, Zugel U, Herfarth HH. Calcitriol analog ZK191784 ameliorates acute and chronic dextran sodium sulfate-induced colitis by modulation of intestinal dendritic cell numbers and phenotype. World J Gastroenterol 13: 6529-6537, 2007.
28. Zaloga GP, Chernow B. The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone-vitamin D axis. Ann Intern Med 107: 36-41, 1987.
29. 3 target the TNF-α pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35: 217-224, 2005.